1.0Lebanon News Gazettehttps://lebanonnewsgazette.comlnadminhttps://lebanonnewsgazette.com/author/lnadmin/BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform - Lebanon News Gazetterich600338<blockquote class="wp-embedded-content" data-secret="yIDyoZgAKt"><a href="https://lebanonnewsgazette.com/biointellisense-closes-oversubscribed-45m-series-b-financing-round-to-scale-its-data-as-a-service-and-clinical-intelligence-platform/">BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform</a></blockquote><iframe sandbox="allow-scripts" security="restricted" src="https://lebanonnewsgazette.com/biointellisense-closes-oversubscribed-45m-series-b-financing-round-to-scale-its-data-as-a-service-and-clinical-intelligence-platform/embed/#?secret=yIDyoZgAKt" width="600" height="338" title="“BioIntelliSense Closes Oversubscribed $45M Series B Financing Round to Scale Its Data-as-a-Service and Clinical Intelligence Platform” — Lebanon News Gazette" data-secret="yIDyoZgAKt" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"></iframe><script> /*! This file is auto-generated */ !function(d,l){"use strict";l.querySelector&&d.addEventListener&&"undefined"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i<o.length;i++)o[i].style.display="none";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute("style"),"height"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):"link"===t.message&&(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document); </script> Strategic funding will support company’s growth and global expansion of continuous multi-parameter monitoring devices and data services for medical grade remote care at scale DENVER, July 28, 2021 /PRNewswire/ — BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced it has recently closed its Series B financing round that was significantly oversubscribed at […]https://ci6.googleusercontent.com/proxy/AndMHAwyfM9_jfimlPIz7E4u3EBpku6qZ4TkhOLBtIvU2SV9reMb7KyGcDmubeFNJoP9uUAd9BzTrVbcJMtjI3WwnhfrJnfPyexlP9UCh09BEGzf=s0-d-e1-ft#https://mma.prnewswire.com/media/1082814/BioIntellisense_Logo.jpg